FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Links shared publicly online about this topic.
- 1,588total visits
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
View full resource at drugs.com
Tags: Heart Disease, High Blood Pressure, Erectile Dysfunction Medication, FDA, Viagra, Pfizer, Pulmonology
Most Recently Shared on November 20, 2009 at 10:30 pm By:
FDA Approves Intravenous Formulation of Revatio (sildenafil) for Pulmonary Arterial Hypertension - http://bit.ly/8HeF3h
European Commission Approves New Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
medicalnewstoday.com — “Pfizer Inc. announced that the European Commission has approved Revatio® (sildenafil) solution for injection for patients who are currently prescribed oral Revatio and who are temporarily unab” View full resource at medicalnewstoday.com
Most Recently Shared on January 6, 2010 at 3:38 am By:
European Commission Approves New Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pul.. http://bit.ly/4EKq6X
Intravenous Revatio approved for pulmonary arterial hypertension (PAH) - MPR
empr.com — “The FDA has approved Revatio (sildenafil, from Pfizer) injection, an intravenous phosphodiesterase-5 (PDE-5) inhibitor, for the treatment of adults with pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and delay clinical worsening.” View full resource at empr.com
Most Recently Shared on November 20, 2009 at 3:51 pm By:
MPR News: Intravenous Revatio approved for pulmonary arterial hypertension (PAH): The FDA has approved Revatio (sil... http://bit.ly/3fobnx
Advertisement
